2022 Final Service Conference and Graduation Awards

The following recipients were recently honored with awards at the Final Service Conference.

Student Teaching Awards          

  • PGY 1: Sarah Tsou, MD, and Dan Hoffman, MD
  • PGY 2: Sangki Oak, MD
  • PGY 3: Kerri McKie, MD
  • PGY 4: Karan Chhabra, MD
  • PGY 5: Sasha Mahvi, MD (the Robert T. Osteen Award for Medical Student Education in Surgery)

    Surgery Class of ’63 Scholar: Sourav Bose, MD

PBB Scholar Award: Sasha Mahvi, MD, and Katherine He, MD

Grant Rodkey Award (VA Hospital Award): Lily Saadat, MD, and Laura Piechura, MD

Christine Weeks Schofield Award (South Shore Hospital Award): Alex Ordoobadi, MD

Edward Kwasnik Award (South Shore Hospital Award): Joshua Jolissaint, MD

The Vollman Award (Faulkner Hospital Award): Kerri McKie, MD

Starfish Award: Jim Fitzgibbon, MD

Francis D. Moore, Sr. Award: Sasha Mahvi, MD

Donald D. Matson Award: Robert Riviello, MD

Richard E. Wilson Award: Matthew Nehs, MD

Joseph E. Murray and Simon J. Simonian Award: Matthew Nehs (mentor)/Brian Zhao (mentee) and Douglas Smink (mentor)/Rachel Atkinson (mentee)

Douglas S. Smink, MD, MPH, Promoted to Professor of Surgery at Harvard Medical School

Chief of Surgery, Brigham and Women’s Faulkner Hospital
Vice Chair for Education,
Department of Surgery
Professor of Surgery,
Harvard Medical School

Dr. Smink received his medical degree from the University of Pennsylvania School of Medicine, completed general surgery residency at the Brigham and a minimally invasive surgery fellowship at Dartmouth-Hitchcock Medical Center. 

Dr. Smink also serves as the editor-in-chief of the Journal of Surgical Education and is a member of the Academy of Master Surgeon Educators through the American College of Surgeons.

Dr. Smink’s research focuses on resident and faculty education through simulation, team training and coaching. He is the co-PI on an NIH grant, the Provider Awareness and Cultural dexterity Toolkit for Surgeons (PACTS), a curriculum to improve surgeon communication with culturally diverse patients. In addition, he is the co-director of the Surgical Coaching for Operative Performance Enhancement (SCOPE) Program at Ariadne Labs, where he helps lead a program of peer-coaching and performance improvement for surgeons. His clinical interests include abdominal wall hernias, foregut surgery and biliary tract disease.

Jennifer L. Guerriero, PhD, Awarded a $2.4M NIH Grant

Dr. Guerriero has been awarded a $2.4M NIH grant for the study, “Immunometabolic pathways enabled by PARP inhibition in breast cancer.”

Macrophages are highly suppressive in the breast tumor and contribute to chemo and immunotherapy resistance. Dr. Guerriero’s lab recently identified that PARP inhibitors (PARPi), a commonly used cancer therapy, induce lipogenic metabolism in TAMs, rendering them even more suppressive, which in turn drives them to inhibit T-cell function and activation and limit therapeutic responses. This work will investigate how lipogenic macrophage and T-cell metabolism in breast cancer is regulated during PARPi therapy, which is likely to provide opportunities for the development of novel treatment strategies that hold the power to overcome the immune-suppressive tumor microenvironment and improve PARPi therapy success in a number of cancer types.

Jennifer Guerriero, PhD
Lead Investigator, Division of Breast Surgery
Director, Breast Immunology Laboratory, Dana-Farber Susan F. Smith Women’s Cancer Program
Assistant Professor of Surgery, Harvard Medical School

Dr. Guerriero graduated from Northeastern University with a BS in biochemistry. She obtained a PhD in immunology and pathology and molecular and cellular biology at Stony Brook University. She completed a postdoctoral fellowship in medical oncology at Dana-Farber Cancer Institute.

Dr. Guerriero is an instructor of medicine at Harvard Medical School. She is a member of the American Association for Cancer Research (AACR); the Society for Immunotherapy of Cancer (SITC), where she is the chair of the Early Career Scientist Committee; and the American Society of Clinical Oncology (ASCO). She is a working group member of the Immuno-Oncology interest group and the TNBC breast group of the Translational Breast Cancer Research Consortium (TBCRC), which conducts innovative and high-impact clinical trials for breast cancer.

Dr. Guerriero’s research interests include harnessing the anti-tumor potential of tumor-associated macrophages for breast cancer immunotherapy, understanding how breast cancer cell intrinsic mutations regulate the tumor microenvironment, and elucidating the biology, diversity and ontogeny of tumor macrophages in breast tumors. The major goal of the breast immunology lab is to perform in-depth analysis of animal models and patient samples to efficiently guide rational use and development of immunotherapy modalities for the treatment of breast cancer.